Case Control Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Dec 14, 2024; 30(46): 4880-4903
Published online Dec 14, 2024. doi: 10.3748/wjg.v30.i46.4880
Table 2 Correlation of human leukocyte antigen-DP and human leukocyte antigen-DQ polymorphisms with the risk of chronic active hepatitis B, n (%)
SNPsHealthy controlHBV carrier
Healthy control vs CHB
Healthy control vs HBV carrier
CHB
HBV-related LC
HBV-related HCC
OR (95%CI)
P value
OR (95%CI)
P value
rs2856718
GG106 (33.7)173 (36.7)100 (40.0)87 (34.7)11
AG149 (47.3)208 (44.2)97 (38.8)119 (47.4)0.855 (0.621-1.179)0.33920.838 (0.630-1.115)0.2253
AA60 (19.0)90 (19.1)53 (21.2)45 (17.9)0.919 (0.612-1.380)0.68400.923 (0.642-1.326)0.6631
AA + AG209 (66.3)298 (63.3)150 (60.0)164 (65.3)0.874 (0.648-1.179)0.37670.862 (0.660-1.127)0.2774
G allele361 (57.3)554 (58.8)297 (59.4)293 (58.4)11
A allele269 (42.7)384 (41.2)203 (40.6)209 (41.6)0.930 (0.758-1.141)0.48820.939 (0.782-1.126)0.4937
rs3077
GG133 (42.2)246 (52.2)128 (51.2)152 (60.5)11
AG139 (44.1)196 (41.6)107 (42.8)84 (33.50.762 (0.563-1.032)0.07020.704 (0.537-0.924)0.0113
AA43 (13.7)29 (6.2)15 (6.0)15 (6.0)0.365 (0.218-0.611)0.00010.347 (0.224-0.537)< 0.0001
AA + AG182 (57.8)225 (47.8)122 (48.8)99 (39.5)0.668 (0.501-0.891)0.00600.620 (0.479-0.801)0.0003
G allele405 (64.3)688 (73.0)364 (72.5)388 (77.3)11
A allele225 (35.7)254 (27.0)138 (27.5)114 (22.7)0.665 (0.535-0.826)0.00020.632 (0.521-0.765)< 0.0001
rs9277535
GG159 (50.5)275 (58.4)142 (56.8)154 (61.4)11
AG123 (39.0)187 (39.7)95 (38.0)88 (35.0)0.879 (0.651-1.186)0.39930.838 (0.640-1.097)0.1972
AA33 (10.5)9 (1.9)13 (5.2)9 (3.6)0.158 (0.074-0.338)< 0.00010.262 (0.155-0.440)< 0.0001
AA + AG156 (49.5)196 (41.6)108 (43.2)97 (38.6)0.726 (0.545-0.968)0.02900.716 (0.555-0.924)0.0102
G allele441 (70.0)737 (78.1)379 (75.8)396 (78.9)11
A allele189 (30.0)205 (21.9)121 (24.2)106 (21.1)0.649 (0.516-0.817)0.00020.667 (0.545-0.815)0.0001